Skip to content

Efficacy of a Non-invasive Device for Alleviation of Parkinson's Disease Symptoms

Efficacy Investigation of a Non-invasive Wearable Electrostimulation Device for Alleviation of Parkinson's Disease Symptoms

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02722824
Enrollment
24
Registered
2016-03-30
Start date
2015-11-30
Completion date
2016-06-30
Last updated
2017-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

motor symptoms

Brief summary

Investigation efficacy of a non-invasive wearable electrostimulator device where the supplementary motor area, premotor area and/or subthalamic nucleus are stimulated bilaterally and extracranially.

Interventions

OTHERPlacebo

Sponsors

Istanbul University
CollaboratorOTHER
Koç University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Parkinson's Disease * H&Y Stage \>= 2 * Existing bradykinesia symptoms * Existence of one of the symptoms below * Resting Tremor * Rigidity * Walking disorder

Exclusion criteria

* Cardiac Pacemaker * Psychiatric diagnosis * Irregular heart/respiration rate * Pregnancy * Alcohol consumption * Cardiovascular disease history * Wearing an electro-active prosthesis * Brain surgery history * Ongoing TENS/PENS therapy

Design outcomes

Primary

MeasureTime frameDescription
Change in the UPDRS Motor Score (Part III)10 minutes after the stimulation is initiated.Evaluation of patients' disease level with UPDRS examination at the middle of the stimulation

Secondary

MeasureTime frameDescription
Change in the gait and balance parameters (cadence)10 minutes after the stimulation is initiated.cadence
Change in the gait and balance parameters (Stride length)10 minutes after the stimulation is initiated.Stride length in meters
Change in the gait and balance parameters (Stride velocity)10 minutes after the stimulation is initiated.Stride velocity in m/s
Change in the gait and balance parameters10 minutes after the stimulation is initiated.Arm Swing Rate

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026